首页> 外文期刊>Analytical methods >LC-MS/MS based quantitation of ciprofloxacin and its application to antimicrobial resistance study in Balb/c mouse plasma, urine, bladder and kidneys
【24h】

LC-MS/MS based quantitation of ciprofloxacin and its application to antimicrobial resistance study in Balb/c mouse plasma, urine, bladder and kidneys

机译:基于LC-MS / MS的CiProfloxacin定量及其在BALB / C小鼠血浆,尿液,膀胱和肾脏中的抗微生物性研究的应用

获取原文
获取原文并翻译 | 示例
           

摘要

The authors proposed a simple, high throughput liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for the determination of ciprofloxacin in small sample volumes of plasma, urine, bladder and kidneys of mice. d(8)-Ciprofloxacin was used as an internal standard (IS) which efficiently tracked the matrix effect in different matrices. The method employed 20 mL of plasma/30 mL of urine or tissue homogenate for sample processing using a simple protein precipitation technique. The processed samples were chromatographed on a C-18 column by using a mixture of 5 mM ammonium formate (0.1% formic acid)-acetonitrile as the mobile phase at a flow rate of 0.6 mL min(-1) with a gradient elution for 3 min. The calibration curve obtained was linear over the concentration range of 100-5000 ng mL(-1) with r(2) = 0.99 in all matrices. Method validation was performed as per FDA guidelines and the results met the acceptance criteria. The multiple reaction-monitoring mode (MRM) was used for the quantification of ion transitions at m/z 332.1/230.8 and 340.1/296.1 for the analyte and the IS, respectively. The validated method was used for preclinical studies of antimicrobial resistance in mice.
机译:作者提出了一种简单的高通量液相色谱 - 串联质谱(LC-MS / MS)方法,用于测定小鼠小样品,尿液,膀胱和小鼠肾脏的小样品体积中的环丙沙星。 D(8)-CiProfloxacin用作内标(IS),其有效地跟踪不同基质中的基质效果。该方法采用20ml等离子体/ 30ml尿液或组织均匀物质用于使用简单的蛋白质沉淀技术进行样品加工。通过使用5mM甲酸铵(0.1%甲酸) - 乙腈作为流动相的混合物以0.6mL min(-1)的流速,将处理后的样品在C-18柱上进行色谱分离。闵。获得的校准曲线在100-5000ng ml(-1)的浓度范围内是线性的,在所有基质中= 0.99 = 0.99。方法验证按FDA指南执行,结果符合验收标准。多次反应监测模式(MRM)用于分析物的M / Z 332.1 / 230.8和340.1 / 296.1的离子转变。验证的方法用于小鼠抗微生物抗性的临床前研究。

著录项

  • 来源
    《Analytical methods》 |2018年第10期|共10页
  • 作者单位

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

    US FDA Ctr Drug Evaluat &

    Res Off Translat Sci Off Clin Pharmacol Div Appl Regulatory Sci Silver Spring MD 20993 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分析化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号